![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Raiteri, B Garrone and A Pittaluga
Istituto di Farmacologia e Farmacognosia, Universita degli Studi di Genova, Italy.
The possible interactions between activation of N-methyl-D-aspartic acid (NMDA) receptors and non-NMDA receptors regulating the release of [3H]norepinephrine [( 3H]NE) have been investigated in superfused synaptosomes from rat hippocampus. NMDA--at a concentration (100 microM) which, in a medium containing 1.2 mM Mg++ ions, did not evoke [3H]NE release--acquired releasing activity in the presence of equimolar concentrations of quisqualic acid (QA), (RS)-alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) or kainic acid. The [3H] NE release evoked by NMDA plus QA in the presence of Mg++ ions was Ca(++)-dependent, partly tetrodotoxin-sensitive, inhibited by clonidine but insensitive to desipramine. The NMDA receptor antagonists D-2-amino- 5-phosphonopentanoic acid (D-AP5) and (+)-5-methyl-10,11-dihydro-5-H- dibenzo[a,d]cycloepten-5,10-imine (MK-801) antagonized the NMDA-induced [3H]NE release in Mg(++)-free medium; the IC50 values amounted, respectively, to 81.4 microM and to 1.11 microM. When NMDA was tested in the presence of QA and Mg++ ions, the affinity of D-AP5 was enormously increased (IC50 = 40 nM; i.e., more than 6 orders of magnitude); the affinity of MK-801 was found to be augmented by 350- fold.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  W. Cui, A. Smith, A. Darby-King, C. W. Harley, and J. H. McLean A temporal-specific and transient cAMP increase characterizes odorant classical conditioning Learn. Mem., March 2, 2007; 14(3): 126 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Ryder, J. F. Falcone, J. R. Manro, K. A. Svensson, and K. M. Merchant Pharmacological Characterization of cGMP Regulation by the Biarylpropylsulfonamide Class of Positive, Allosteric Modulators of {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 293 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Longordo, M. Feligioni, G. Chiaramonte, P. F. Sbaffi, M. Raiteri, and A. Pittaluga The Human Immunodeficiency Virus-1 Protein Transactivator of Transcription Up-Regulates N-Methyl-D-aspartate Receptor Function by Acting at Metabotropic Glutamate Receptor 1 Receptors Coexisting on Human and Rat Brain Noradrenergic Neurones J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1097 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pittaluga, M. Feligioni, F. Longordo, M. Arvigo, and M. Raiteri Somatostatin-Induced Activation and Up-Regulation of N-Methyl-D-aspartate Receptor Function: Mediation through Calmodulin-Dependent Protein Kinase II, Phospholipase C, Protein Kinase C, and Tyrosine Kinase in Hippocampal Noradrenergic Nerve Endings J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-R. Lu, S. J. Hwang, K. D. Phend, A. Rustioni, and J. G. Valtschanoff Primary Afferent Terminals in Spinal Cord Express Presynaptic AMPA Receptors J. Neurosci., November 1, 2002; 22(21): 9522 - 9529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Meir, S. Ginsburg, A. Butkevich, S. G. Kachalsky, I. Kaiserman, R. Ahdut, S. Demirgoren, and R. Rahamimoff Ion Channels in Presynaptic Nerve Terminals and Control of Transmitter Release Physiol Rev, July 1, 1999; 79(3): 1019 - 1088. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
